Show
Sort by
-
Identification of novel genes associated with systemic sclerosis through genome wide association study follow-up
-
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis a phase I randomized, double-blind, placebo-controlled, proof-of-concept study
-
CD248 and its cytoplasmic domain: a therapeutic target for Arthritis
-
Invariant natural killer T cells are natural regulators of murine spondylarthritis
-
Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability
-
Validation of a manual ability questionnaire in patients with systemic sclerosis
-
Differential expression of alpha B-crystallin and evidence of its role as a mediator of matrix gene expression in osteoarthritis
-
Differential mechanism of NF-κB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts
-
Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with Infliximab
-
Tumor Necrosis Factor alpha Drives Cadherin 11 Expression in Rheumatoid Inflammation